載入...

Systemic treatment for metastatic prostate cancer

The management of metastatic prostate cancer (mPCa) has changed over the past ten years. Several new drugs have been approved with significant overall survival benefits in metastatic castration resistant prostate cancer (PCa) including chemotherapy (docetaxel, cabazitaxel), new hormonal therapies (a...

全面介紹

Na minha lista:
書目詳細資料
發表在:Asian J Urol
主要作者: Gravis, Gwenaelle
格式: Artigo
語言:Inglês
出版: Second Military Medical University 2019
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6488732/
https://ncbi.nlm.nih.gov/pubmed/31061802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajur.2019.02.002
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!